{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:42:32Z","timestamp":1794357752084,"version":"4.9.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272232"],"award-info":[{"award-number":["82272232"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170775"],"award-info":[{"award-number":["82170775"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370765"],"award-info":[{"award-number":["82370765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Calcium oxalate (CaOx) is the most common type of kidney stone, and its crystal deposition can induce oxidative stress, inflammatory responses, and cell death. This further aggravates kidney structural and functional damage, which in turn, promotes kidney stone recurrence, forming a vicious cycle of repeated stone formation and renal injury. Therefore, identifying precise and effective therapeutic targets is crucial to prevent the damage and inflammation caused by kidney stones. Protein arginine methyltransferase 1 (PRMT1) is a well-known epigenetic regulatory enzyme involved in renal metabolic reprogramming. However, the role of PRMT1-mediated arginine methylation in kidney stone-induced renal injury remains unclear. In this study, mice with specific deletion or overexpression of PRMT1 in tubular epithelial cells were developed, and a CaOx crystal-induced kidney injury mouse model was established. Single-cell RNA-sequencing, metabolomic, proteomic, and transcriptomic analyses, together with immunoprecipitation, mass spectrometry, GST-pulldown assays, oxygen consumption rate assays, and other methods, were used to reveal the mechanism of PRMT1 in renal injury caused by CaOx crystals. Specifically, PRMT1 enhanced the protein function of UBE2m through arginine methylation at R169, and increased the neddylation level and protein stability of NEDD4, thereby inducing PPAR\u03b3 ubiquitination. Increased PPAR\u03b3 degradation inhibited downstream fatty acid metabolism, leading to renal lipid accumulation, disrupted energy metabolism, and impaired kidney function. These findings provide a novel potential therapeutic target for CaOx kidney stones.<\/jats:p>","DOI":"10.1038\/s41419-025-07888-3","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T18:26:03Z","timestamp":1753986363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["PRMT1-mediated methylation of UBE2m promoting calcium oxalate crystal-induced kidney injury by inhibiting fatty acid metabolism"],"prefix":"10.1038","volume":"16","author":[{"given":"Tianhui","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5938-4403","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8090-0501","authenticated-orcid":false,"given":"Xiangjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3471-6221","authenticated-orcid":false,"given":"Fan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"7888_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.eururo.2012.03.052","volume":"62","author":"CD Scales Jr","year":"2012","unstructured":"Scales CD Jr, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in the United States. Eur Urol. 2012;62:160\u20135. https:\/\/doi.org\/10.1016\/j.eururo.2012.03.052.","journal-title":"Eur Urol"},{"key":"7888_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.1","volume":"3","author":"SR Khan","year":"2017","unstructured":"Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, et al. Kidney stones. Nat Rev Dis Prim. 2017;3:17001. https:\/\/doi.org\/10.1038\/nrdp.2017.1.","journal-title":"Nat Rev Dis Prim"},{"key":"7888_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13578-023-01041-3","volume":"13","author":"Z Wang","year":"2023","unstructured":"Wang Z, Deng Q, Gu Y, Li M, Chen Y, Wang J, et al. Integrated single-nucleus sequencing and spatial architecture analysis identified distinct injured-proximal tubular types in calculi rats. Cell Biosci. 2023;13:92. https:\/\/doi.org\/10.1186\/s13578-023-01041-3.","journal-title":"Cell Biosci"},{"key":"7888_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38975-8","volume":"14","author":"VH Canela","year":"2023","unstructured":"Canela VH, Bowen WS, Ferreira RM, Syed F, Lingeman JE, Sabo AR, et al. A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease. Nat Commun. 2023;14:4140. https:\/\/doi.org\/10.1038\/s41467-023-38975-8.","journal-title":"Nat Commun"},{"key":"7888_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/mou.0000000000001066","volume":"33","author":"G Capolongo","year":"2023","unstructured":"Capolongo G, Ferraro PM, Unwin R. Inflammation and kidney stones: cause and effect? Curr Opin Urol. 2023;33:129\u201335. https:\/\/doi.org\/10.1097\/mou.0000000000001066.","journal-title":"Curr Opin Urol"},{"key":"7888_CR6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.juro.2016.05.090","volume":"196","author":"D Assimos","year":"2016","unstructured":"Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, et al. Surgical management of stones: American Urological Association\/EndourologicalSociety guideline, PART I. J Urol. 2016;196:1153\u201360. https:\/\/doi.org\/10.1016\/j.juro.2016.05.090.","journal-title":"J Urol"},{"key":"7888_CR7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41582-019-0188-y","volume":"15","author":"S Kaneko","year":"2019","unstructured":"Kaneko S, Takeda N. Roles of metabolic reprogramming in kidney fibrosis. Nat Rev Nephrol. 2019;15:353\u201366.","journal-title":"Nat Rev Nephrol"},{"key":"7888_CR8","first-page":"2053","volume":"58","author":"GY Goh","year":"2017","unstructured":"Goh GY, Ebert TE. Renal lipid metabolism and lipotoxicity. J Lipid Res. 2017;58:2053\u201370.","journal-title":"J Lipid Res"},{"key":"7888_CR9","first-page":"269","volume":"1658","author":"KJ Kelly","year":"2004","unstructured":"Kelly KJ, Scarpulla RC. Mitochondrial biogenesis and remodeling during myogenesis. Biochim Biophys Acta. 2004;1658:269\u201379.","journal-title":"Biochim Biophys Acta"},{"key":"7888_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang HM, Ahn SH, Choi P, Ko YA, Han SH, Chinga F, et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med. 2015;21:37\u201346. https:\/\/doi.org\/10.1038\/nm.3762.","journal-title":"Nat Med"},{"key":"7888_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcel.2008.12.013","volume":"33","author":"MT Bedford","year":"2009","unstructured":"Bedford MT, Clarke SG. Protein arginine methylation in mammals: who, what, and why. Mol Cell. 2009;33:1\u201313. https:\/\/doi.org\/10.1016\/j.molcel.2008.12.013.","journal-title":"Mol Cell"},{"key":"7888_CR12","first-page":"4367","volume":"76","author":"L Wang","year":"2019","unstructured":"Wang L, Zhao Y. Protein arginine methylation regulators in kidney disease. Cell Mol Life Sci. 2019;76:4367\u201383.","journal-title":"Cell Mol Life Sci"},{"key":"7888_CR13","first-page":"eaaf6761","volume":"10","author":"RS Blanc","year":"2017","unstructured":"Blanc RS, Richard S. Arginine methylation by PRMT1 controls mTORC1 signaling. Sci Signal. 2017;10:eaaf6761.","journal-title":"Sci Signal"},{"key":"7888_CR14","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3390\/life11111147","volume":"11","author":"C Thiebaut","year":"2021","unstructured":"Thiebaut C, Eve L, Poulard C, Le Romancer M. Structure, activity, and function of PRMT1. Life. 2021;11:1147. https:\/\/doi.org\/10.3390\/life11111147.","journal-title":"Life"},{"key":"7888_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.phrs.2009.07.006","volume":"60","author":"TB Nicholson","year":"2009","unstructured":"Nicholson TB, Chen T, Richard S. The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation. Pharm Res. 2009;60:466\u201374. https:\/\/doi.org\/10.1016\/j.phrs.2009.07.006.","journal-title":"Pharm Res"},{"key":"7888_CR16","first-page":"3554","volume":"35","author":"N Gao","year":"2016","unstructured":"Gao N, Zhang X, Song X, He H, Liu Z, Wang Z. Protein arginine methyltransferase 1 promotes renal cell carcinoma metastasis via the regulation of Snail. Oncogene. 2016;35:3554\u201364.","journal-title":"Oncogene"},{"key":"7888_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","volume":"12","author":"DA Guertin","year":"2007","unstructured":"Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell. 2007;12:9\u201322. https:\/\/doi.org\/10.1016\/j.ccr.2007.05.008.","journal-title":"Cancer Cell"},{"key":"7888_CR18","doi-asserted-by":"publisher","unstructured":"Ye C, Jiang W, Hu T, Liang J, Chen Y. The regulatory impact of CFLAR methylation modification on liver lipid metabolism. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms25147897.","DOI":"10.3390\/ijms25147897"},{"key":"7888_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102309","volume":"298","author":"Q Zhu","year":"2022","unstructured":"Zhu Q, Wang D, Liang F, Tong X, Liang Z, Wang X, et al. Protein arginine methyltransferase PRMT1 promotes adipogenesis by modulating transcription factors C\/EBP\u03b2 and PPAR\u03b3. J Biol Chem. 2022;298:102309. https:\/\/doi.org\/10.1016\/j.jbc.2022.102309.","journal-title":"J Biol Chem"},{"key":"7888_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cell.2015.02.041","volume":"161","author":"L Chantranupong","year":"2015","unstructured":"Chantranupong L, Wolfson RL, Sabatini DM. Nutrient-sensing mechanisms across evolution. Cell. 2015;161:67\u201383. https:\/\/doi.org\/10.1016\/j.cell.2015.02.041.","journal-title":"Cell"},{"key":"7888_CR21","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1097\/01.asn.0000016444.90348.50","volume":"13","author":"X Shao","year":"2002","unstructured":"Shao X, Somlo S, Igarashi P. Epithelial-specific Cre\/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrology. 2002;13:1837\u201346. https:\/\/doi.org\/10.1097\/01.asn.0000016444.90348.50.","journal-title":"J Am Soc Nephrology"},{"key":"7888_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06098-y","volume":"7","author":"S Tong","year":"2017","unstructured":"Tong S, Si Y, Yu H, Zhang L, Xie P, Jiang W. MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma. Sci Rep. 2017;7:5599. https:\/\/doi.org\/10.1038\/s41598-017-06098-y.","journal-title":"Sci Rep"},{"key":"7888_CR23","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1097\/01.asn.0000016443.50138.cd","volume":"13","author":"X Shao","year":"2002","unstructured":"Shao X, Johnson JE, Richardson JA, Hiesberger T, Igarashi P. A minimal Ksp-cadherin promoter linked to a green fluorescent protein reporter gene exhibits tissue-specific expression in the developing kidney and genitourinary tract. J Am Soc Nephrol. 2002;13:1824\u201336. https:\/\/doi.org\/10.1097\/01.asn.0000016443.50138.cd.","journal-title":"J Am Soc Nephrol"},{"key":"7888_CR24","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00280-018-3582-z","volume":"81","author":"B Xu","year":"2018","unstructured":"Xu B, Deng Y, Bi R, Guo H, Shu C, Shah NK, et al. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification. Cancer Chemother Pharm. 2018;81:1083\u201393. https:\/\/doi.org\/10.1007\/s00280-018-3582-z.","journal-title":"Cancer Chemother Pharm"},{"key":"7888_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1158\/2767-9764.Crc-22-0340","volume":"3","author":"TM Jones","year":"2023","unstructured":"Jones TM, Espitia CM, Chipollini J, Lee BR, Wertheim JA, Carew JS, et al. Targeting NEDDylation is a novel strategy to attenuate cisplatin-induced nephrotoxicity. Cancer Res Commun. 2023;3:245\u201357. https:\/\/doi.org\/10.1158\/2767-9764.Crc-22-0340.","journal-title":"Cancer Res Commun"},{"key":"7888_CR26","doi-asserted-by":"publisher","first-page":"F650","DOI":"10.1152\/ajprenal.1997.273.4.F650","volume":"273","author":"JA Schafer","year":"1997","unstructured":"Schafer JA, Watkins ML, Li L, Herter P, Haxelmans S, Schlatter E. A simplified method for isolation of large numbers of defined nephron segments. Am J Physiol. 1997;273:F650\u20137. https:\/\/doi.org\/10.1152\/ajprenal.1997.273.4.F650. Oct.","journal-title":"Am J Physiol"},{"key":"7888_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1681\/asn.2009060615","volume":"22","author":"S Lee","year":"2011","unstructured":"Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrology. 2011;22:317\u201326. https:\/\/doi.org\/10.1681\/asn.2009060615.","journal-title":"J Am Soc Nephrology"},{"key":"7888_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"7888_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/15548627.2017.1409405","volume":"14","author":"K Wang","year":"2018","unstructured":"Wang K, Zhang T, Lei Y, Li X, Jiang J, Lan J, et al. Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding TFEB-mediated autophagic flux. Autophagy. 2018;14:269\u201382. https:\/\/doi.org\/10.1080\/15548627.2017.1409405.","journal-title":"Autophagy"},{"key":"7888_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114925","volume":"164","author":"Z Ye","year":"2023","unstructured":"Ye Z, Xia Y, Li L, Li B, Chen L, Yu W, et al. p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis. Biomed Pharmacother. 2023;164:114925. https:\/\/doi.org\/10.1016\/j.biopha.2023.114925.","journal-title":"Biomed Pharmacother"},{"key":"7888_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04793-1","volume":"22","author":"X Yan","year":"2024","unstructured":"Yan X, Xia Y, Li B, Ye Z, Li L, Yuan T, et al. The SOX4\/EZH2\/SLC7A11 signaling axis mediates ferroptosis in calcium oxalate crystal deposition-induced kidney injury. J Transl Med. 2024;22:9. https:\/\/doi.org\/10.1186\/s12967-023-04793-1.","journal-title":"J Transl Med"},{"key":"7888_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309234","volume":"11","author":"Z He","year":"2024","unstructured":"He Z, Song C, Li S, Dong C, Liao W, Xiong Y, et al. Development and application of the CRISPR-dcas13d-eIF4G translational regulatory system to inhibit ferroptosis in calcium oxalate crystal-induced kidney injury. Adv Sci. 2024;11:e2309234. https:\/\/doi.org\/10.1002\/advs.202309234.","journal-title":"Adv Sci"},{"key":"7888_CR33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/bib\/bbw041","volume":"18","author":"W Deng","year":"2017","unstructured":"Deng W, Wang Y, Ma L, Zhang Y, Ullah S, Xue Y. Computational prediction of methylation types of covalently modified lysine and arginine residues in proteins. Brief Bioinform. 2017;18:647\u201358. https:\/\/doi.org\/10.1093\/bib\/bbw041.","journal-title":"Brief Bioinform"},{"key":"7888_CR34","doi-asserted-by":"publisher","first-page":"D719","DOI":"10.1093\/nar\/gkab962","volume":"50","author":"X Wang","year":"2022","unstructured":"Wang X, Li Y, He M, Kong X, Jiang P, Liu X, et al. UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase\/deubiquitinase-substrate interactions in eukaryotic species. Nucleic Acids Res. 2022;50:D719\u2013d28. https:\/\/doi.org\/10.1093\/nar\/gkab962.","journal-title":"Nucleic Acids Res"},{"key":"7888_CR35","doi-asserted-by":"publisher","first-page":"e1009401","DOI":"10.1371\/journal.ppat.1009401","volume":"17","author":"C Li","year":"2021","unstructured":"Li C, Zhang L, Qian D, Cheng M, Hu H, Hong Z, et al. RNF111-facilitated neddylation potentiates cGAS-mediated antiviral innate immune response. PLoS Pathog. 2021;17:e1009401. https:\/\/doi.org\/10.1371\/journal.ppat.1009401.","journal-title":"PLoS Pathog"},{"key":"7888_CR36","doi-asserted-by":"publisher","first-page":"34096","DOI":"10.1074\/jbc.M603654200","volume":"281","author":"IR Watson","year":"2006","unstructured":"Watson IR, Blanch A, Lin DCC, Ohh M, Irwin MS. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function. J Biol Chem. 2006;281:34096\u2013103.","journal-title":"J Biol Chem"},{"key":"7888_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00018-023-05078-y","volume":"81","author":"Y Hou","year":"2024","unstructured":"Hou Y, Tan E, Shi H, Ren X, Wan X, Wu W, et al. Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney. Cell Mol Life Sci. 2024;81:23. https:\/\/doi.org\/10.1007\/s00018-023-05078-y.","journal-title":"Cell Mol Life Sci"},{"key":"7888_CR38","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","volume":"19","author":"A Mitrofanova","year":"2023","unstructured":"Mitrofanova A, Merscher S, Fornoni A. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat Rev Nephrol. 2023;19:629\u201345. https:\/\/doi.org\/10.1038\/s41581-023-00741-w.","journal-title":"Nat Rev Nephrol"},{"key":"7888_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.kint.2024.02.025","volume":"106","author":"LE Lee","year":"2024","unstructured":"Lee LE, Doke T, Mukhi D, Susztak K. The key role of altered tubule cell lipid metabolism in kidney disease development. Kidney Int. 2024;106:24\u201334. https:\/\/doi.org\/10.1016\/j.kint.2024.02.025.","journal-title":"Kidney Int"},{"key":"7888_CR40","doi-asserted-by":"crossref","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","volume":"312","author":"M Cirino","year":"2017","unstructured":"Cirino M, Neri D. Inflammation and fibrosis in CKD: knowns and unknowns. Am J Physiol-Ren Physiol. 2017;312:F716\u2013F731.","journal-title":"Am J Physiol-Ren Physiol"},{"key":"7888_CR41","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.2337\/db20-1050","volume":"70","author":"S Choi","year":"2021","unstructured":"Choi S, Choi D, Lee YK, Ahn SH, Seong JK, Chi SW, et al. Depletion of Prmt1 in adipocytes impairs glucose homeostasis in diet-induced obesity. Diabetes. 2021;70:1664\u201378. https:\/\/doi.org\/10.2337\/db20-1050.","journal-title":"Diabetes"},{"key":"7888_CR42","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202256128","volume":"24","author":"D Yang","year":"2023","unstructured":"Yang D, Fan Y, Xiong M, Chen Y, Zhou Y, Liu X, et al. Loss of renal tubular G9a benefits acute kidney injury by lowering focal lipid accumulation via CES1. EMBO Rep. 2023;24:e56128. https:\/\/doi.org\/10.15252\/embr.202256128.","journal-title":"EMBO Rep"},{"key":"7888_CR43","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2010.07.053","volume":"213","author":"RG Fassett","year":"2010","unstructured":"Fassett RG, Robertson IK, Ball MJ, Geraghty DP, Coombes JS. Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial. Atherosclerosis. 2010;213:218\u201324. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.07.053.","journal-title":"Atherosclerosis"},{"key":"7888_CR44","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1001\/jama.2016.0548","volume":"315","author":"Billings","year":"2016","unstructured":"Billings, FTt, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, et al. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877\u201388. https:\/\/doi.org\/10.1001\/jama.2016.0548.","journal-title":"JAMA"},{"key":"7888_CR45","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.7150\/thno.40395","volume":"10","author":"H Yu","year":"2020","unstructured":"Yu H, Jin F, Liu D, Shu G, Wang X, Qi J, et al. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury. Theranostics. 2020;10:2342\u201357. https:\/\/doi.org\/10.7150\/thno.40395.","journal-title":"Theranostics"},{"key":"7888_CR46","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1111\/dom.15640","volume":"26","author":"X Xuan","year":"2024","unstructured":"Xuan X, Zhang Y, Song Y, Zhang B, Liu J, Liu D, et al. Role of protein arginine methyltransferase 1 in obesity-related metabolic disorders: research progress and implications. Diab, Obes Metab. 2024;26:3491\u2013500. https:\/\/doi.org\/10.1111\/dom.15640.","journal-title":"Diab, Obes Metab"},{"key":"7888_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113385","volume":"42","author":"WJ Li","year":"2023","unstructured":"Li WJ, Huang Y, Lin YA, Zhang BD, Li MY, Zou YQ, et al. Targeting PRMT1-mediated SRSF1 methylation to suppress oncogenic exon inclusion events and breast tumorigenesis. Cell Rep. 2023;42:113385. https:\/\/doi.org\/10.1016\/j.celrep.2023.113385.","journal-title":"Cell Rep"},{"key":"7888_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38443-3","volume":"14","author":"J Liu","year":"2023","unstructured":"Liu J, Bu X, Chu C, Dai X, Asara JM, Sicinski P, et al. PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity. Nat Commun. 2023;14:2806. https:\/\/doi.org\/10.1038\/s41467-023-38443-3.","journal-title":"Nat Commun"},{"key":"7888_CR49","doi-asserted-by":"publisher","first-page":"28557","DOI":"10.1074\/jbc.272.45.28557","volume":"272","author":"T Kamitani","year":"1997","unstructured":"Kamitani T, Kito K, Nguyen HP, Yeh ET. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem. 1997;272:28557\u201362. https:\/\/doi.org\/10.1074\/jbc.272.45.28557.","journal-title":"J Biol Chem"},{"key":"7888_CR50","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1089\/ars.2013.5795","volume":"21","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Morgan MA, Sun Y. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy. Antioxid Redox Signal. 2014;21:2383\u2013400. https:\/\/doi.org\/10.1089\/ars.2013.5795.","journal-title":"Antioxid Redox Signal"},{"key":"7888_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/srep42845","volume":"7","author":"T Sakaue","year":"2017","unstructured":"Sakaue T, Sakakibara I, Uesugi T, Fujisaki A, Nakashiro KI, Hamakawa H, et al. The CUL3-SPOP-DAXX axis is a novel regulator of VEGFR2 expression in vascular endothelial cells. Sci Rep. 2017;7:42845. https:\/\/doi.org\/10.1038\/srep42845.","journal-title":"Sci Rep"},{"key":"7888_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbrc.2016.04.058","volume":"474","author":"J Shu","year":"2016","unstructured":"Shu J, Liu C, Wei R, Xie P, He S, Zhang L. Nedd8 targets ubiquitin ligase Smurf2 for neddylation and promote its degradation. Biochem Biophys Res Commun. 2016;474:51\u201356. https:\/\/doi.org\/10.1016\/j.bbrc.2016.04.058.","journal-title":"Biochem Biophys Res Commun"},{"key":"7888_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4733","volume":"5","author":"P Xie","year":"2014","unstructured":"Xie P, Zhang M, He S, Lu K, Chen Y, Xing G, et al. The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesis. Nat Commun. 2014;5:3733. https:\/\/doi.org\/10.1038\/ncomms4733.","journal-title":"Nat Commun"},{"key":"7888_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep41364","volume":"7","author":"S He","year":"2017","unstructured":"He S, Cao Y, Xie P, Dong G, Zhang L. The Nedd8 non-covalent binding region in the Smurf HECT domain is critical to its ubiquitn ligase function. Sci Rep. 2017;7:41364. https:\/\/doi.org\/10.1038\/srep41364.","journal-title":"Sci Rep"},{"key":"7888_CR55","doi-asserted-by":"publisher","first-page":"9671","DOI":"10.3892\/mmr.2017.7803","volume":"16","author":"J Zhao","year":"2017","unstructured":"Zhao J, Zhang B, Lai G, Xu R, Chu G, Zhao Y. 20-Hydroxyeicosatetraenoic acid regulates the expression of Nedd4\u20112 in kidney and liver through a neddylation modification pathway. Mol Med Rep. 2017;16:9671\u20137. https:\/\/doi.org\/10.3892\/mmr.2017.7803.","journal-title":"Mol Med Rep"},{"key":"7888_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.111958","volume":"390","author":"J Tu","year":"2020","unstructured":"Tu J, Zhang B, Fang G, Chang W, Zhao Y. Neddylation-mediated Nedd4-2 activation regulates ubiquitination modification of renal NBCe1. Exp Cell Res. 2020;390:111958. https:\/\/doi.org\/10.1016\/j.yexcr.2020.111958.","journal-title":"Exp Cell Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07888-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07888-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07888-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T09:47:06Z","timestamp":1757324826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07888-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7888"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07888-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"COMPETING INTERESTS"}},{"value":"Samples were obtained with informed consent, and all protocols were performed in accordance with the Declaration of Helsinki and were approved by the review board of Renmin Hospital of Wuhan University (WDRY2021-KS047). Informed consent was obtained from patients. Animal experiments were approved by the Animal Care and Use Committee of Renmin Hospital of Wuhan University (WDRM 20200604), which complied with the Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23). All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"579"}}